Literature DB >> 7913750

Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII.

V C Yee1, L C Pedersen, I Le Trong, P D Bishop, R E Stenkamp, D C Teller.   

Abstract

Mechanical stability in many biological materials is provided by the crosslinking of large structural proteins with gamma-glutamyl-epsilon-lysyl amide bonds. The three-dimensional structure of human recombinant factor XIII (EC 2.3.2.13 zymogen; protein-glutamine:amine gamma-glutamyltransferase a chain), a transglutaminase zymogen, has been solved at 2.8-A resolution by x-ray crystallography. This structure shows that each chain of the homodimeric protein is folded into four sequential domains. A catalytic triad reminiscent of that observed in cysteine proteases has been identified in the core domain. The amino-terminal activation peptide of each subunit crosses the dimer interface and partially occludes the opening of the catalytic cavity in the second subunit, preventing substrate binding to the zymogen. A proposal for the mechanism of activation by thrombin and calcium is made that details the structural events leading to active factor XIIIa'.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913750      PMCID: PMC44386          DOI: 10.1073/pnas.91.15.7296

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Human platelet factor V is crosslinked to actin by FXIIIa during platelet activation by thrombin.

Authors:  D L Wang; A E Annamalai; S Ghosh; A M Gewirtz; R W Colman
Journal:  Thromb Res       Date:  1990-01-01       Impact factor: 3.944

2.  Peptides incorporating electrophilic glutamine analogues as potential transglutaminase inhibitors.

Authors:  P M Doyle; C J Harris; K R Carter; D S Simpkin; P Bailey-Smith; D Stone; L Russell; G J Blackwell
Journal:  Biochem Soc Trans       Date:  1990-12       Impact factor: 5.407

3.  Amino acid sequence of the a subunit of human factor XIII.

Authors:  A Ichinose; L E Hendrickson; K Fujikawa; E W Davie
Journal:  Biochemistry       Date:  1986-11-04       Impact factor: 3.162

4.  Factor XIIIa in the hamartomas of tuberous sclerosis.

Authors:  N S Penneys; K J Smith; A J Nemeth
Journal:  J Dermatol Sci       Date:  1991-01       Impact factor: 4.563

5.  Inhibitors of fibrin cross-linking: relevance for thrombolysis.

Authors:  J B Lorand; T R Pilkington; L Lorand
Journal:  Nature       Date:  1966-06-18       Impact factor: 49.962

6.  Expression, purification, and characterization of human factor XIII in Saccharomyces cerevisiae.

Authors:  P D Bishop; D C Teller; R A Smith; G W Lasser; T Gilbert; R L Seale
Journal:  Biochemistry       Date:  1990-02-20       Impact factor: 3.162

7.  Crystallographic studies of the binding of protonated and unprotonated inhibitors to carbonic anhydrase using hydrogen sulphide and nitrate anions.

Authors:  S Mangani; K Håkansson
Journal:  Eur J Biochem       Date:  1992-12-15

8.  Alterations of haemostasis parameters with special reference to fibrin stabilization, factor XIII and fibronectin in patients with obliterative atherosclerosis.

Authors:  J Kłoczko; M Wojtukiewicz; M Bielawiec; A Zuch
Journal:  Thromb Res       Date:  1988-09-15       Impact factor: 3.944

9.  The deduced sequence of the novel protransglutaminase E (TGase3) of human and mouse.

Authors:  I G Kim; J J Gorman; S C Park; S I Chung; P M Steinert
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

10.  Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction.

Authors:  C W Francis; D G Connaghan; W L Scott; V J Marder
Journal:  Circulation       Date:  1987-06       Impact factor: 29.690

View more
  65 in total

1.  A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides.

Authors:  Z Yang; I Mochalkin; R F Doolittle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  A superfamily of archaeal, bacterial, and eukaryotic proteins homologous to animal transglutaminases.

Authors:  K S Makarova; L Aravind; E V Koonin
Journal:  Protein Sci       Date:  1999-08       Impact factor: 6.725

3.  The 1.6-A crystal structure of the class of chaperones represented by Escherichia coli Hsp31 reveals a putative catalytic triad.

Authors:  Paulene M Quigley; Konstantin Korotkov; Francois Baneyx; Wim G J Hol
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-05       Impact factor: 11.205

4.  A role for N-glycanase in the cytosolic turnover of glycoproteins.

Authors:  Christian Hirsch; Daniël Blom; Hidde L Ploegh
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

5.  Deficiency of factor XIII gene in Chinese: 3 novel mutations.

Authors:  Baohua Duan; Xuefeng Wang; Haiyan Chu; Yiqun Hu; Xiaping Huang; Bin Qu; Hongli Wang; Zhenyi Wang
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

6.  Transglutaminase 1 mutations in autosomal recessive congenital ichthyosis: private and recurrent mutations in an isolated population.

Authors:  E Laiho; J Ignatius; H Mikkola; V C Yee; D C Teller; K M Niemi; U Saarialho-Kere; J Kere; A Palotie
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

7.  Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function.

Authors:  Vytautas Ivaskevicius; Arijit Biswas; Carville Bevans; Verena Schroeder; Hans Peter Kohler; Hannelore Rott; Susan Halimeh; Petro E Petrides; Harald Lenk; Manuele Krause; Bruno Miterski; Ursula Harbrecht; Johannes Oldenburg
Journal:  Haematologica       Date:  2010-02-23       Impact factor: 9.941

8.  Solution structure of a late embryogenesis abundant protein (LEA14) from Arabidopsis thaliana, a cellular stress-related protein.

Authors:  Shanteri Singh; Claudia C Cornilescu; Robert C Tyler; Gabriel Cornilescu; Marco Tonelli; Min S Lee; John L Markley
Journal:  Protein Sci       Date:  2005-09-09       Impact factor: 6.725

Review 9.  Modeling thrombin generation: plasma composition based approach.

Authors:  Kathleen E Brummel-Ziedins; Stephen J Everse; Kenneth G Mann; Thomas Orfeo
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

10.  Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis.

Authors:  Sunando Datta; Marc A Antonyak; Richard A Cerione
Journal:  Biochemistry       Date:  2006-11-07       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.